Aisha S. Sie

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition

Janet R. Vos, Ingrid E. Fakkert, Joanne A. de Hullu et al. · JNCI Journal of the National Cancer Institute · 2019 · 69 citations · Full text

Medicine, Genetics, Oncology +17

Novel<i>BRCA1</i>and<i>BRCA2</i>Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas

Robbert D.A. Weren, Arjen R. Mensenkamp, Michiel Simons et al. · Human Mutation · 2016 · 64 citations · Full text

Medicine, Molecular Genetics, Oncology +17

More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling

Aisha S. Sie, Wendy A.G. van Zelst–Stams, Liesbeth Spruijt et al. · Familial Cancer · 2013 · 46 citations · Full text

Life Sciences, Genetics, Oncology +11

High Satisfaction and Low Distress in Breast Cancer Patients One Year after <i>BRCA</i>‐Mutation Testing without Prior Face‐to‐Face Genetic Counseling

Aisha S. Sie, Liesbeth Spruijt, Wendy A.G. van Zelst–Stams et al. · Journal of Genetic Counseling · 2015 · 34 citations · Full text

Life Sciences, Genetics, Oncology +14

Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective

Aisha S. Sie, Arjen R. Mensenkamp, E. M. Adang et al. · Annals of Oncology · 2014 · 27 citations · Full text

Medicine, Genetics, Oncology +13